Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
Radiation pneumonitis (RP) has been related to various clinical and radiation dosimetric factors such as mean lung equivalent dose in 2 Gy fractions (ML-EQD2). Here we test the hypothesis that other factors impact grade 2 or higher RP within 6 months of radiotherapy (RT) (≥G2RP) when ML-EQD2 is cont...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Elsevier
2017
|
| _version_ | 1826275052967952384 |
|---|---|
| author | Vivekanandan, S Landau, DB Counsell, N Warren, DR Farrelly, L Ngai, Y Hawkins, MA Fenwick, JD |
| author_facet | Vivekanandan, S Landau, DB Counsell, N Warren, DR Farrelly, L Ngai, Y Hawkins, MA Fenwick, JD |
| author_sort | Vivekanandan, S |
| collection | OXFORD |
| description | Radiation pneumonitis (RP) has been related to various clinical and radiation dosimetric factors such as mean lung equivalent dose in 2 Gy fractions (ML-EQD2). Here we test the hypothesis that other factors impact grade 2 or higher RP within 6 months of radiotherapy (RT) (≥G2RP) when ML-EQD2 is controlled via isotoxic dose-escalation. |
| first_indexed | 2024-03-06T22:52:50Z |
| format | Conference item |
| id | oxford-uuid:5f5db11e-cd1d-4ada-ac9d-13a62a614379 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:52:50Z |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:5f5db11e-cd1d-4ada-ac9d-13a62a6143792022-03-26T17:46:32ZClinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLCConference itemhttp://purl.org/coar/resource_type/c_5794uuid:5f5db11e-cd1d-4ada-ac9d-13a62a614379Symplectic Elements at OxfordElsevier2017Vivekanandan, SLandau, DBCounsell, NWarren, DRFarrelly, LNgai, YHawkins, MAFenwick, JDRadiation pneumonitis (RP) has been related to various clinical and radiation dosimetric factors such as mean lung equivalent dose in 2 Gy fractions (ML-EQD2). Here we test the hypothesis that other factors impact grade 2 or higher RP within 6 months of radiotherapy (RT) (≥G2RP) when ML-EQD2 is controlled via isotoxic dose-escalation. |
| spellingShingle | Vivekanandan, S Landau, DB Counsell, N Warren, DR Farrelly, L Ngai, Y Hawkins, MA Fenwick, JD Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title | Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title_full | Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title_fullStr | Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title_full_unstemmed | Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title_short | Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC |
| title_sort | clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose escalated nsclc |
| work_keys_str_mv | AT vivekanandans clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT landaudb clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT counselln clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT warrendr clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT farrellyl clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT ngaiy clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT hawkinsma clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc AT fenwickjd clinicalanddosimetricfactorsimpactingradiationpneumonitisinisotoxicallydoseescalatednsclc |